MARKET NEWS

Atlas Nanotech Targets the World’s Largest Consumer Health Products Companies
CURE Pharmaceutical Takes First Step to Acquire Coeptis Pharmaceuticals
PromoCell Now Offers In Vitro Disease Models That Could Lead to New Therapies
New Study From Tufts Center for the Study of Drug Development Establishes Benchmarks
Centogene Signs Collaboration Agreement With Pfizer
Aravive & AstraZeneca Announce Initiation of Randomized Phase 1/2 Study

  FEATURED EDITORIAL

  COMPANY PROFILE

 

 

Backed by over 85 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on injectable pharmaceutical manufacturing designed to meet complex and traditional sterile manufacturing challenges with confidence of delivery, service, and integrity. BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the high-quality products we manufacture for our clients in a cGMP environment. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Protalix BioTherapeutics & Chiesi Farmaceutici Announce Successful Pre-BLA Meeting 

Protalix BioTherapeutics & Chiesi Farmaceutici Announce Successful Pre-BLA Meeting 

Protalix BioTherapeutics, Inc. and its development and commercialization partner, Chiesi Farmaceutici S.p.A. recently announced that they have completed a successful Type B Pre-Biologics License Application (BLA) meeting with the US FDA regarding….

Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Drug

Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Drug

Seelos Therapeutics, Inc. recently announced the US FDA has granted Fast Track designation to its new, investigational intranasal racemic ketamine program, SLS-002, for the treatment of…..

Cytel Acquires MTEK Sciences, Further Expanding Advanced Real-World Analytics Capabilities

Cytel Acquires MTEK Sciences, Further Expanding Advanced Real-World Analytics Capabilities

Cytel Inc. recently announced that it has acquired MTEK Sciences to further expand its advanced real-world analytics (RWA) capabilities….

Vetter’s US Site Offers Clinical Manufacturing for Successful Drug Development of Injectables

Vetter’s US Site Offers Clinical Manufacturing for Successful Drug Development of Injectables

Pharma and biotech companies, both large and small, have high expectations for their new molecules they have in development. Even the smallest of details can impact the eventual success or failure of their product…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

November 27 – Injection Devices
December 4 – Capsules